Label: REPLENIX LIP THERAPY HOMOSALATE- homosalate lipstick

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph not final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated February 2, 2023

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • ACTIVE INGREDIENT

    Active ingredientsPurpose
    Homosalate 15.0%Sunscreen
    Octinoxate 7.5%Sunscreen
    Octisalate 5.0%Sunscreen
    Avobenzone 3.0%Sunscreen
  • Uses

    • Helps prevent sunburn
    • If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.
  • Warnings

    For lip application only.

    This product delivers a temporary tingling sensation to the lips. Only apply product inside the line of your lips.

    When using this product keep out of eyes, rinse with water to remove.

    Stop use if signs of irritation or rash appear. If irritation or rash persists consult a doctor.

    Keep out of reach of children.

    In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately.

  • Directions

    Apply a generous coat to bare lips as often as desired, staying inside the lip line. Visible volume and natural color typically lasts 1-2 hours. Individual results may vary.

    • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sunscreen measures including:
      • limit time in the sun, especially from 10a.m.-2 p.m.
      • wear long-sleeve shirts, pants, hats, and sunglasses
  • Inactive ingredients

    Hydrogenated Polyisobutene, Ethylene/Propylene/Styrene Copolymer, Butylene/Ethylene/Styrene Copolymer, Octocrylene, Benzyl Nicotinate, Glycerin, Cetearyl Ethylhexanoate, Sorbitan Isostearate, Portulaca Pilosa Extract, Sucrose Cocoate, Pa l m i t o y l Tripeptide-38, Sodium Hyaluronate, Menthone Glycerin Acetal, Stevia Rebaudiana Leaf/Stem Powder, Niacinamide, Tocopheryl Acetate, Hydrolyzed Sodium Hyaluronate, Glutathione, Ergothioneine, Ceramide NP, Ceramide AP, Ceramide EOP, Phytosphingosine, Cholesterol, Sodium Lauroyl Lactylate, Carbomer, Xanthan Gum, Yucca Schidigera Root Extract, Salix Alba (Willow) Bark Extract, Panthenol, Essential Oil of Spearmint (Mentha Viridis), Essential Oil of Peppermint (Mentha Piperita), Flavor.

  • PRINCIPAL DISPLAY PANEL - 4 ml Bottle Carton

    REPLENIX®
    PURE HYDRATION

    Plumping Lip Treatment
    Broad Spectrum SPF 30 Sunscreen

    Net 0.14 fl. oz. (4 ml)

    Topix Pharmaceuticals, Inc. N. Amityville, NY 11701

    PRINCIPAL DISPLAY PANEL - 4 ml Bottle Carton
  • INGREDIENTS AND APPEARANCE
    REPLENIX LIP THERAPY   HOMOSALATE
    homosalate lipstick
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51326-102
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE150 mg  in 1 g
    OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE75 mg  in 1 g
    OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE50 mg  in 1 g
    AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE30 mg  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    HYDROGENATED POLYBUTENE (1300 MW) (UNII: 7D1YQ9Y5EZ)  
    OCTOCRYLENE (UNII: 5A68WGF6WM)  
    BENZYL NICOTINATE (UNII: S497LCF9C9)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    CETEARYL ETHYLHEXANOATE (UNII: 9M64UO4C25)  
    SORBITAN ISOSTEARATE (UNII: 01S2G2C1E4)  
    PORTULACA PILOSA WHOLE (UNII: II29C6E5R3)  
    SUCROSE COCOATE (UNII: 3H18P0UK73)  
    PALMITOYL LYSYLDIOXYMETHIONYLLYSINE (UNII: T7A529FB8O)  
    HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
    MENTHONE 1,2-GLYCEROL KETAL, (+/-)- (UNII: 7QQ1EE6RCP)  
    STEVIA REBAUDIUNA LEAF (UNII: 6TC6NN0876)  
    NIACINAMIDE (UNII: 25X51I8RD4)  
    .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    GLUTATHIONE (UNII: GAN16C9B8O)  
    ERGOTHIONEINE (UNII: BDZ3DQM98W)  
    CERAMIDE NP (UNII: 4370DF050B)  
    CERAMIDE AP (UNII: F1X8L2B00J)  
    CERAMIDE 1 (UNII: 5THT33P7X7)  
    PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q)  
    CHOLESTEROL (UNII: 97C5T2UQ7J)  
    SODIUM LAUROYL LACTYLATE (UNII: 7243K85WFO)  
    CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    YUCCA SCHIDIGERA ROOT (UNII: E2H9ET15AT)  
    SALIX ALBA BARK (UNII: 205MXS71H7)  
    PANTHENOL (UNII: WV9CM0O67Z)  
    SPEARMINT OIL (UNII: C3M81465G5)  
    PEPPERMINT OIL (UNII: AV092KU4JH)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:51326-102-044 g in 1 BOTTLE; Type 0: Not a Combination Product01/02/2022
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC MONOGRAPH NOT FINALpart35201/02/2022
    Labeler - Topiderm, Inc. (049121643)
    Establishment
    NameAddressID/FEIBusiness Operations
    Topiderm, Inc.049121643MANUFACTURE(51326-102)